Published in J Am Coll Cardiol on December 01, 1999
Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis. AIDS (2009) 3.08
Microbial translocation in the pathogenesis of HIV infection and AIDS. Clin Microbiol Rev (2013) 1.82
The gut microbiome, kidney disease, and targeted interventions. J Am Soc Nephrol (2013) 1.67
Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients. Clin J Am Soc Nephrol (2008) 1.65
Soluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients. Am J Kidney Dis (2009) 1.54
Association of soluble endotoxin receptor CD14 and mortality among patients undergoing hemodialysis. Am J Kidney Dis (2009) 1.52
A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese. Diabetes Care (2010) 1.52
Surfactant protein D is expressed and modulates inflammatory responses in human coronary artery smooth muscle cells. Am J Physiol Heart Circ Physiol (2008) 1.47
Gut microbiota and diabetes: from pathogenesis to therapeutic perspective. Acta Diabetol (2011) 1.30
Diabetic complications and dysregulated innate immunity. Front Biosci (2008) 1.28
Molecular mechanisms responsible for the selective and low-grade induction of proinflammatory mediators in murine macrophages by lipopolysaccharide. J Immunol (2012) 1.19
Systemic inflammation in cardiovascular and periodontal disease: comparative study. Clin Diagn Lab Immunol (2002) 1.19
Is the gut microbiota a new factor contributing to obesity and its metabolic disorders? J Obes (2012) 1.16
Role of toll-like receptor 4 in intimal foam cell accumulation in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2010) 1.15
Endotoxin: another phantom menace? J Am Coll Cardiol (1999) 1.15
Innate immune programing by endotoxin and its pathological consequences. Front Immunol (2015) 1.13
T-cell phenotypes, apoptosis and inflammation in HIV+ patients on virologically effective cART with early atherosclerosis. PLoS One (2012) 1.12
Examining associations of circulating endotoxin with nutritional status, inflammation, and mortality in hemodialysis patients. J Ren Nutr (2011) 1.11
Myeloid differentiation primary response protein 88 couples reverse cholesterol transport to inflammation. Cell Metab (2010) 1.01
Infectious complications in dialysis--epidemiology and outcomes. Nat Rev Nephrol (2011) 1.00
Regulation of endotoxin-induced proinflammatory activation in human coronary artery cells: expression of functional membrane-bound CD14 by human coronary artery smooth muscle cells. J Immunol (2004) 1.00
Absence of TRAM restricts Toll-like receptor 4 signaling in vascular endothelial cells to the MyD88 pathway. Circ Res (2006) 0.98
Translational mini-review series on immunology of vascular disease: inflammation, infections and Toll-like receptors in cardiovascular disease. Clin Exp Immunol (2009) 0.96
Endotoxin increase after fat overload is related to postprandial hypertriglyceridemia in morbidly obese patients. J Lipid Res (2012) 0.95
Molecular mechanisms responsible for the reduced expression of cholesterol transporters from macrophages by low-dose endotoxin. Arterioscler Thromb Vasc Biol (2012) 0.95
Activated TLR signaling in atherosclerosis among women with lower Framingham risk score: the multi-ethnic study of atherosclerosis. PLoS One (2011) 0.92
Elevated levels of circulating DNA in cardiovascular disease patients: metagenomic profiling of microbiome in the circulation. PLoS One (2014) 0.91
Relationship between microbial translocation and endothelial function in HIV infected patients. PLoS One (2012) 0.91
Recurrent exposure to subclinical lipopolysaccharide increases mortality and induces cardiac fibrosis in mice. PLoS One (2013) 0.90
Stress induces endotoxemia and low-grade inflammation by increasing barrier permeability. Front Immunol (2015) 0.90
IL-6 serum levels and production is related to an altered immune response in polycystic ovary syndrome girls with insulin resistance. Mediators Inflamm (2011) 0.89
A central role for monocytes in Toll-like receptor-mediated activation of the vasculature. Immunology (2009) 0.89
Myocardial fibrosis induced by exposure to subclinical lipopolysaccharide is associated with decreased miR-29c and enhanced NOX2 expression in mice. PLoS One (2014) 0.89
Microbial translocation and cardiometabolic risk factors in HIV infection. AIDS Res Hum Retroviruses (2014) 0.88
Adiponectin protein exists in aortic endothelial cells. PLoS One (2013) 0.87
The alternative pathway is critical for pathogenic complement activation in endotoxin- and diet-induced atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation (2010) 0.87
Sparstolonin B suppresses lipopolysaccharide-induced inflammation in human umbilical vein endothelial cells. Arch Pharm Res (2013) 0.86
Contribution of vascular cell-derived cytokines to innate and inflammatory pathways in atherogenesis. J Cell Mol Med (2011) 0.86
Blood microbiota dysbiosis is associated with the onset of cardiovascular events in a large general population: the D.E.S.I.R. study. PLoS One (2013) 0.86
mRNA-binding protein ZFP36 is expressed in atherosclerotic lesions and reduces inflammation in aortic endothelial cells. Arterioscler Thromb Vasc Biol (2013) 0.85
Plasma concentrations of bacterial lipopolysaccharide: a marker of infection or inflammation? J Am Coll Cardiol (2000) 0.85
Detection of Chlamydiae pneumoniae but not Helicobacter pylori DNA in atherosclerosis plaques. Dig Dis Sci (2003) 0.85
Differential TNF production by monocyte subsets under physical stress: blunted mobilization of proinflammatory monocytes in prehypertensive individuals. Brain Behav Immun (2012) 0.84
Associations of Soluble CD14 and Endotoxin with Mortality, Cardiovascular Disease, and Progression of Kidney Disease among Patients with CKD. Clin J Am Soc Nephrol (2015) 0.83
Lipopolysaccharide regulated protein expression is only partly impaired in monocytes from patients with type I diabetes. Cardiovasc Diabetol (2006) 0.83
The persistence of low-grade inflammatory monocytes contributes to aggravated atherosclerosis. Nat Commun (2016) 0.83
Low-grade inflammatory polarization of monocytes impairs wound healing. J Pathol (2016) 0.82
Inflammation-induced foam cell formation in chronic inflammatory disease. Immunol Cell Biol (2015) 0.82
Modulation of anti-inflammatory response in lipopolysaccharide stimulated human THP-1 cell line and mouse model at gene expression level with indigenous putative probiotic lactobacilli. Genes Nutr (2013) 0.82
Gender differences in the effect of occupational endotoxin exposure on impaired lung function and death: the Shanghai Textile Worker Study. Occup Environ Med (2013) 0.82
Super-low dose endotoxin pre-conditioning exacerbates sepsis mortality. EBioMedicine (2015) 0.81
Vitamin D3 repletion in chronic kidney disease stage 3: effects on blood endotoxin activity, inflammatory cytokines, and intestinal permeability. Ren Fail (2013) 0.80
1,25(OH)2D3 downregulates the Toll-like receptor 4-mediated inflammatory pathway and ameliorates liver injury in diabetic rats. J Endocrinol Invest (2015) 0.80
The gut microbiome as novel cardio-metabolic target: the time has come! Eur Heart J (2013) 0.79
The CD14 C-260T single nucleotide polymorphism (SNP) modulates monocyte/macrophage activation in treated HIV-infected individuals. J Transl Med (2015) 0.79
Gene polymorphisms contributing to hypertension in immunoglobulin A nephropathy. Clin Exp Nephrol (2011) 0.79
Endotoxemia and the host systemic response during experimental gingivitis. J Clin Periodontol (2011) 0.79
Postprandial Effect of a High-Fat Meal on Endotoxemia in Arab Women with and without Insulin-Resistance-Related Diseases. Nutrients (2015) 0.78
The danger model: questioning an unconvincing theory. Immunol Cell Biol (2015) 0.78
Potent suppression of arginase 1 expression in murine macrophages by low dose endotoxin. Am J Clin Exp Immunol (2013) 0.78
Cardiovascular complications in inflammatory bowel disease. Curr Drug Targets (2015) 0.77
Understanding the expression of Toll-like receptors in Asian Indians predisposed to coronary artery disease. Arch Med Sci (2011) 0.77
Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease in focal cerebral ischemic rats. Am J Neurodegener Dis (2016) 0.77
Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis. Lipids Health Dis (2015) 0.76
Lipopolysaccharide-induced proliferation of the vasa vasorum in a rabbit model of atherosclerosis as evaluated by contrast-enhanced ultrasound imaging and histology. Inflammation (2012) 0.76
Effects of C-reactive Protein and Homocysteine on Cytokine Production: Modulation by Pravastatin. Arch Drug Inf (2008) 0.76
L-4F inhibits lipopolysaccharide-mediated activation of primary human neutrophils. Inflammation (2014) 0.76
Subclinical-Dose Endotoxin Sustains Low-Grade Inflammation and Exacerbates Steatohepatitis in High-Fat Diet-Fed Mice. J Immunol (2016) 0.76
Gut microbiome in chronic kidney disease: challenges and opportunities. Transl Res (2016) 0.76
Abnormal macrophage response to microbial stimulus in a 43-year-old man with a severe form of atherosclerosis: a case report. J Med Case Rep (2010) 0.76
Liver X Receptor: Crosstalk Node for the Signaling of Lipid Metabolism, Carbohydrate Metabolism, and Innate Immunity. Curr Signal Transduct Ther (2008) 0.76
Fecal microbiota transplantation in metabolic syndrome: History, present and future. Gut Microbes (2017) 0.75
Advances in Gut Microbiome Research, Opening New Strategies to Cope with a Western Lifestyle. Front Genet (2017) 0.75
Pilot experience with opebacan/rBPI 21 in myeloablative hematopoietic cell transplantation. F1000Res (2015) 0.75
The effect of prebiotic supplementation with inulin on cardiometabolic health: Rationale, design, and methods of a controlled feeding efficacy trial in adults at risk of type 2 diabetes. Contemp Clin Trials (2015) 0.75
Intestinal Barrier Disturbances in Haemodialysis Patients: Mechanisms, Consequences, and Therapeutic Options. Biomed Res Int (2017) 0.75
Retracted Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease. Am J Neurodegener Dis (2016) 0.75
Relationship between postprandial endotoxemia in nonobese postmenopausal women and diabetic nonobese postmenopausal women. J Nat Sci Biol Med (2015) 0.75
The importance of the presence of aggregatibacter actinomycetemcomitans in sulcus gingivalis of patients with cardiovascular diseases. Med Sci Monit (2011) 0.75
Cationic peptide mR18L with lipid lowering properties inhibits LPS-induced systemic and liver inflammation in rats. Biochem Biophys Res Commun (2013) 0.75
Risk of cardiovascular disease in inflammatory bowel disease. Exp Ther Med (2016) 0.75
Circulating bacterial-derived DNA fragment level is a strong predictor of cardiovascular disease in peritoneal dialysis patients. PLoS One (2015) 0.75
A Novel ASK Inhibitor AGI-1067 Inhibits TLR-4-Mediated Activation of ASK1 by Preventing Dissociation of Thioredoxin from ASK1. Cardiovasc Pharm Open Access (2015) 0.75
Toll-Interacting Protein in Resolving and Non-Resolving Inflammation. Front Immunol (2017) 0.75
Endotoxemia is associated with acute coronary syndrome in patients with end stage kidney disease. BMC Nephrol (2017) 0.75
Dissecting obesogenic environments: the development and application of a framework for identifying and prioritizing environmental interventions for obesity. Prev Med (1999) 8.06
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
An "ecological" approach to the obesity pandemic. BMJ (1997) 5.43
Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet (1993) 4.03
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes (1998) 3.55
Preventive strategies against weight gain and obesity. Obes Rev (2002) 3.15
Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study. Circulation (1999) 3.08
Results of large scale media antismoking campaign in Australia: North Coast "Quit for Life" programme. Br Med J (Clin Res Ed) (1983) 2.97
Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation (2001) 2.82
Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis : clinical significance determined in a follow-up study. Circulation (1999) 2.73
Polyneuropathies in critically ill patients: a prospective evaluation. Intensive Care Med (1996) 2.45
Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study) BMJ (1996) 2.42
Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation (1997) 2.18
Burden of atherosclerosis and risk of venous thromboembolism in patients with migraine. Neurology (2008) 2.16
Examination of postoperative peripheral nerve lesions with high-resolution sonography. AJR Am J Roentgenol (2001) 1.98
Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation (2000) 1.81
Restless legs syndrome: a community-based study of prevalence, severity, and risk factors. Neurology (2005) 1.77
Juvenile asymmetric segmental spinal muscular atrophy (Hirayama's disease): three cases without evidence of "flexion myelopathy". Acta Neurol Scand (2001) 1.74
Sudden infant death syndrome: risk factor profiles for distinct subgroups. Am J Epidemiol (1998) 1.53
Distal myasthenia gravis frequency and clinical course in a large prospective series. Acta Neurol Scand (2003) 1.50
Recanalization after thrombolysis in stroke patients: predictors and prognostic implications. Neurology (2007) 1.48
Poor response to activated protein C as a prominent risk predictor of advanced atherosclerosis and arterial disease. Circulation (1999) 1.46
Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions. Am J Pathol (1993) 1.46
Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. J Clin Invest (1995) 1.45
The natural course of atherosclerosis. Part II: vascular remodeling. Bruneck Study Group. Arterioscler Thromb Vasc Biol (1999) 1.40
Chorea as the presenting clinical feature of primary antiphospholipid syndrome in childhood. Neuropediatrics (1999) 1.40
Carotid endarterectomy within seven days after the neurological index event is safe and effective in stroke prevention. Eur J Vasc Endovasc Surg (2011) 1.38
Pre- and postnatal medical care and risk of sudden infant death syndrome. Acta Paediatr (1997) 1.38
The natural course of atherosclerosis. Part I: incidence and progression. Arterioscler Thromb Vasc Biol (1999) 1.35
Systematically missing confounders in individual participant data meta-analysis of observational cohort studies. Stat Med (2009) 1.27
Impaired glucose tolerance, Type II diabetes mellitus and carotid atherosclerosis: prospective results from the Bruneck Study. Diabetologia (2000) 1.23
Overexpression of p27(Kip1) by doxycycline-regulated adenoviral vectors inhibits endothelial cell proliferation and migration and impairs angiogenesis. FASEB J (2001) 1.21
Functional recovery after ischemic stroke--a matter of age: data from the Austrian Stroke Unit Registry. Neurology (2012) 1.21
Alcohol consumption and atherosclerosis: what is the relation? Prospective results from the Bruneck Study. Stroke (1998) 1.09
Effect of inhibitors of Na+/H+-exchange and gastric H+/K+ ATPase on cell volume, intracellular pH and migration of human polymorphonuclear leucocytes. Br J Pharmacol (1998) 1.09
B lymphocyte-derived IL-16 attracts dendritic cells and Th cells. J Immunol (2000) 1.07
Epidemiology of apparent life threatening events. Arch Dis Child (2005) 1.05
Alcohol consumption and carotid atherosclerosis: evidence of dose-dependent atherogenic and antiatherogenic effects. Results from the Bruneck Study. Stroke (1994) 1.05
Early clinical worsening in patients with TIA or minor stroke: the Austrian Stroke Unit Registry. Neurology (2010) 1.05
Prevalence and risk factors of asymptomatic extracranial carotid artery atherosclerosis. A population-based study. Arterioscler Thromb (1993) 1.04
A role for IL-16 in the cross-talk between dendritic cells and T cells. J Immunol (1999) 1.04
Screening for carnitine palmitoyltransferase II deficiency by tandem mass spectrometry. J Inherit Metab Dis (2002) 1.03
Metabolic syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study. Int J Obes Relat Metab Disord (2003) 1.02
Can the increasing weight of Australians be explained by the decreasing prevalence of cigarette smoking? Int J Obes Relat Metab Disord (1994) 1.02
Magnetic resonance imaging in the diagnosis of spinal cord diseases. J Neurol Neurosurg Psychiatry (1985) 1.01
Two families with autosomal dominant progressive external ophthalmoplegia. J Neurol Neurosurg Psychiatry (2004) 0.99
Distinct risk profiles of early and advanced atherosclerosis: prospective results from the Bruneck Study. Arterioscler Thromb Vasc Biol (2000) 0.99
Are plasma VEGF and its soluble receptor sFlt-1 atherogenic risk factors? Cross-sectional data from the SAPHIR study. Atherosclerosis (2009) 0.99
Vascular endothelial growth factor in CSF: a biological marker for carcinomatous meningitis. Neurology (2000) 0.98
Body iron stores and presence of carotid atherosclerosis. Results from the Bruneck Study. Arterioscler Thromb (1994) 0.98